
Adma Biologics, Inc.
ADMANasdaqCIK 1368514HealthcareFiscal year ends Dec 31
Reports and events: 394 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2024-02-2816:21 ET | 8-K | 5.02 Departure or appointment of officers or directors; 8.01 Other events; 9.01 Financial statements and exhibits | 0001140361-24-010100 |
| 2024-02-2816:15 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001140361-24-010088 |
| 2024-02-2108:00 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001140361-24-008680 |
| 2024-01-0808:00 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001140361-24-001198 |
| 2024-01-0807:30 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001140361-24-001194 |
| 2023-12-1816:30 ET | 8-K | 1.01 Entry into a material agreement; 1.02 Termination of a material agreement; 2.03 New direct financial obligation; 8.01 Other events; 9.01 Financial statements and exhibits | 0001140361-23-058160 |
| 2023-12-1216:30 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001140361-23-057341 |
| 2023-11-1616:31 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001140361-23-053665 |
| 2023-11-0817:00 ET | 10-Q | Quarterly reportPeriod 2023-09-30 | 0001140361-23-052109 |
| 2023-11-0816:36 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001140361-23-052102 |
| 2023-10-0216:45 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001140361-23-046335 |
| 2023-08-0917:05 ET | 10-Q | Quarterly reportPeriod 2023-06-30 | 0001140361-23-038843 |
| 2023-08-0916:15 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001140361-23-038803 |
| 2023-07-1907:30 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001140361-23-035123 |
| 2023-06-0616:30 ET | 8-K | 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001140361-23-028551 |
| 2023-05-2207:30 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001140361-23-025873 |
| 2023-05-1017:00 ET | 10-Q | Quarterly reportPeriod 2023-03-31 | 0001140361-23-023920 |
| 2023-05-1016:15 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001140361-23-023899 |
| 2023-05-0209:07 ET | 8-K | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 8.01 Other events; 9.01 Financial statements and exhibits | 0001140361-23-022312 |
| 2023-04-1316:31 ET | DEF 14A | Proxy statementPeriod 2023-06-06 | 0001140361-23-018237 |
| 2023-03-2317:16 ET | 10-K | Annual reportPeriod 2022-12-31 | 0001140361-23-013467 |
| 2023-03-2316:15 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001140361-23-013402 |
| 2023-03-1016:50 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001140361-23-011200 |
| 2023-02-0807:22 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001140361-23-005120 |
| 2023-01-1708:30 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001140361-23-001727 |
| 2022-12-0917:00 ET | SC 13D/A | Ownership report, active investor, amended | 0000902664-22-005090 |
| 2022-12-0916:30 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001140361-22-045106 |
| 2022-12-0709:01 ET | 8-K | 1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0001140361-22-044667 |
| 2022-12-0616:19 ET | 8-K | 2.02 Results of operations; 8.01 Other events; 9.01 Financial statements and exhibits | 0001140361-22-044592 |
| 2022-11-0917:16 ET | 10-Q | Quarterly reportPeriod 2022-09-30 | 0001140361-22-040738 |
| 2022-11-0916:16 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001140361-22-040700 |
| 2022-10-3116:30 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001140361-22-039119 |
| 2022-08-1017:26 ET | 10-Q | Quarterly reportPeriod 2022-06-30 | 0001140361-22-029116 |
| 2022-08-1016:15 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001140361-22-029079 |
| 2022-06-2716:30 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001140361-22-024139 |
| 2022-06-2117:00 ET | 8-K | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001140361-22-023666 |
| 2022-06-1316:30 ET | 8-K | 8.01 Other events | 0001140361-22-022769 |
| 2022-05-1116:45 ET | 10-Q | Quarterly reportPeriod 2022-03-31 | 0001140361-22-018668 |
| 2022-05-1116:16 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001140361-22-018655 |
| 2022-04-2816:36 ET | DEF 14A | Proxy statementPeriod 2022-06-21 | 0001140361-22-016578 |
| 2022-03-2516:30 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001140361-22-011213 |
| 2022-03-2417:16 ET | 10-K | Annual reportPeriod 2021-12-31 | 0001140361-22-011030 |
| 2022-03-2417:13 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001140361-22-011028 |
| 2022-03-0917:17 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001140361-22-008654 |
| 2022-03-0716:30 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001140361-22-008174 |
| 2022-02-0408:30 ET | SC 13D | Ownership report, active investor | 0000902664-22-001112 |
| 2022-01-1908:30 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001140361-22-001914 |
| 2022-01-1808:30 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001140361-22-001782 |
| 2021-12-2116:48 ET | 8-K | 1.01 Entry into a material agreement; 3.03 Change to security holders’ rights; 5.03 Amendment to articles or bylaws; 8.01 Other events; 9.01 Financial statements and exhibits | 0001140361-21-042611 |
| 2021-12-0908:30 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001140361-21-040956 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Nov 10, 2026, 16:34 ET. Listed shows no prices and gives no investment advice.